Need a specific person's email?
Browse Rigel Pharmaceuticals Inc.'s employee directory (about 288 employees) and reveal verified emails free.
Rigel Pharmaceuticals Inc.'s most common email format is FLast@rigel.com (ex. JDoe@rigel.com), used for 92% of rigel.com addresses. Rigel Pharmaceuticals Inc. uses 4 email patterns.
| Format | Example | Share of rigel.com |
|---|---|---|
| FLast@rigel.comMost common | JDoe@rigel.com | |
| FirstL@rigel.com | JohnD@rigel.com | |
| FirstLast@rigel.com | JohnDoe@rigel.com | |
| Last@rigel.com | Doe@rigel.com |
Browse Rigel Pharmaceuticals Inc.'s employee directory (about 288 employees) and reveal verified emails free.
Biotechnology ResearchCalifornia, United States201-500 Employees
Rigel Pharmaceuticals, Inc. is a biotechnology company headquartered in South San Francisco, California, focused on discovering, developing, and providing novel small molecule drugs for hematologic disorders and cancer. It operates in the biotechnology research industry and employs between 201 and 500 people. The company has pursued strategic collaborations for its pipeline, including an exclusive global license with Arvinas and Pfizer for Veppanu (vepdegestrant), a PROTAC therapeutic candidate. Rigel previously partnered with Eli Lilly on ocadusertib, a RIPK1 inhibitor, but that license and collaboration ended in 2021. In 2025, Rigel added Dr. Mark J. Frohlich to its board of directors, reflecting governance changes. In 2025 the company announced a development agreement with Kissei to develop Rezlidhia in Asia, with potential future payments up to $152 million.
Most common format
FLast@rigel.com
Example: JDoe@rigel.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.